HEM Pharma Inc. (KOSDAQ:376270)

South Korea flag South Korea · Delayed Price · Currency is KRW
79,900
-600 (-0.75%)
At close: Feb 27, 2026
346.12%
Market Cap 573.02B
Revenue n/a
Net Income n/a
Shares Out 7.17M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 24,374
Average Volume 49,449
Open 79,700
Previous Close 80,500
Day's Range 78,900 - 81,100
52-Week Range 17,420 - 97,500
Beta n/a
RSI 54.82
Earnings Date Feb 13, 2026

About HEM Pharma

HEM Pharma Inc. operates as a microbiome healthcare company in South Korea and internationally. The company offers health functional food products, such as Nutrilite and my LAB microbiome solution. It also engages in the personalized analysis service and CDMO businesses. The company was founded in 2016 and is based in Pohang, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 2016
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 376270
Full Company Profile

News

There is no news available yet.